Circulating Tumor DNA Based Adjuvant Chemotherapy in Stage II Colon Cancer Patients: the MEDOCC-CrEATE Trial

Abroad (travel likely)Recruiting

Conditions

Circulating Tumor DNA · Recurrence · Colon Cancer Stage II

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Jeroen Bosch Ziekenhuis, 's-Hertogenbosch, Netherlands

    Contact: Study coordinator (M.L. Wumkes)
  • Noordwest Ziekenhuisgroep, Alkmaar, Netherlands

    Contact: Study coordinator (M.P. Hendriks)
  • Ziekenhuisgroep Twente, Almelo, Netherlands

    Contact: Study coordinator (R. Hoekstra)
  • Flevoziekenhuis, Almere Stad, Netherlands

    Contact: Study coordinator (J.D.W. van der Bilt)
  • Meander Medisch Centrum, Amersfoort, Netherlands

    Contact: Study coordinator (J.M. van Dodewaard)
  • NKI-AVL, Amsterdam, Netherlands

    Contact: Study coordinator (K. Bolhuis)
  • Rijnstate, Arnhem, Netherlands

    Contact: Study coordinator (I. Werter)
  • Amphia Ziekenhuis, Breda, Netherlands

    Contact: Study coordinator (M. Streppel)
  • Reinier de Graaf Gasthuis, Delft, Netherlands

    Contact: Study coordinator (A.J. Verschoor)
  • Deventer Ziekenhuis, Deventer, Netherlands

    Contact: Study coordinator (L.W. Kessels)
  • Albert Schweizer Ziekenhuis, Dordrecht, Netherlands

    Contact: Study coordinator (M. Vidakovic)
  • Ziekenhuis Gelderse Vallei, Ede, Netherlands

    Contact: Study coordinator (M. Verstappen)
  • Admiraal de Ruyter Ziekenhuis, Goes, Netherlands

    Contact: Study coordinator (H.K. van Halteren)
  • Rivas, Gorinchem, Netherlands

    Contact: Study coordinator (M.A. Davidis)
  • Spaarne Gasthuis, Haarlem, Netherlands

    Contact: Study coordinator (H.B.A.C. Stockmann)
  • Ziekenhuis St. Jansdal, Harderwijk, Netherlands

    Contact: Study coordinator (A.P. Schouten van der Velden)
  • Maastricht UMC, Maastricht, Netherlands

    Contact: Study coordinator (L.B.J. Valkenburg)
  • Van Weel-Bethesda Ziekenhuis, Middelharnis, Netherlands

    Contact: Study coordinator (A. Dietvorst)
  • St. Antonius Ziekenhuis, Nieuwegein, Netherlands

    Contact: Study coordinator (M. Los)
  • Canisius Wilhelmina Ziekenhuis, Nijmegen, Netherlands

    Contact: Study coordinator (J. Janssen)
  • Bravis Ziekenhuis, Roosendaal, Netherlands

    Contact: Study coordinator (S. Boudewijns)
  • Ikazia Ziekenhuis, Rotterdam, Netherlands

    Contact: Study coordinator (F.E. de Jongh)
  • Haaglanden MC, The Hague, Netherlands

    Contact: Study coordinator (F.J.F. Jeurissen)
  • Bernhoven, Uden, Netherlands

    Contact: Study coordinator (J. van Extel)
  • Diakonessenhuis, Utrecht, Netherlands

    Contact: Study coordinator (L. van Leeuwen)
  • UMC Utrecht, Utrecht, Netherlands

    Contact: Study coordinator (Miriam Koopman)
  • Maxima Medisch Centrum, Veldhoven, Netherlands

    Contact: Study coordinator (L.H.J Simkens)
  • VieCuri Medisch Centrum, Venlo, Netherlands

    Contact: Study coordinator (J. Konsten)
  • St. Jans Gasthuis, Weert, Netherlands

    Contact: Study coordinator (N.A.J.B. Peters)